Nanomedicine News

RSS

Forbes Honors Nanomedicine Researcher on Top Rising Stars in Science and Health List

Pedro Valencia, who earned his PhD in chemical engineering at MIT in November, was named in Forbes magazine's 2012 list of the top 30 rising stars in science and health.

From Massachusetts Institute of Technology 27 Dec 2012

NanoViricides Receives Final Tranche of $2.5M Financing from Seaside

NanoViricides, Inc. (the "Company"), announced today that it has received the final tranche of $2.5M from Seaside 88, LP (“Seaside”), thereby completing the total of a $5M financing. This raise, and the receipt of the initial $2.5M tranche, was previously announced on June 29, 2012.

From NanoViricides, Inc 26 Dec 2012

Nanomedicine Company Blend Secures $16M Series B Financing

Blend Therapeutics, Inc., a biopharmaceutical company discovering new classes of medicines to treat debilitating diseases, announced today that it has secured a $16 million Series B financing. Blend is pioneering an integrative model for discovering novel molecular entities with new mechanisms of action purposely designed for Blend’s proprietary nanoparticles. By synergistically developing both the molecule and the nanoparticle together, Blend can make medicines more targeted, more effective and more tolerable.

26 Dec 2012

NCKU, ANL to Jointly Compete for I-RiCE Center on Nanocarbon Technology

Taiwan’s National Cheng Kung University (NCKU) and America’s Argonne National Laboratory (ANL), which have enjoyed close collaborative ties for years, are planning to jointly compete for an International Research-Intensive Centers for Excellence (I-RiCE) center on nanocarbon technology.

26 Dec 2012

Sirnaomics Achieves Major Breakthrough in its Nanoparticle-Based siRNA Therapeutics Product

Sirnaomics, Inc. announced today that the company has made a major breakthrough in its novel small interfering RNA (siRNA) therapeutic product against human papillomavirus (HPV) infection and cervical cancer which was presented by Dr. Alan Lu , Executive Vice President of Sirnaomics, in the 28th International Papillomavirus Conference held in San Juan, Puerto Rico from Nov 30th to Dec 6th, 2012.

21 Dec 2012

Nanomedicine Company MagForce to Raise €33.5 Million

MagForce AG (Frankfurt, Xetra: MF6), a leading medical device company in the field of nanomedicine with a focus on oncology, today announced that the Company, with the approval of the Supervisory Board, has resolved a restructuring plan to safeguard MagForce's long-term existence.

From MagForce Nanotechnologies AG 20 Dec 2012

Business Card-Sized Device Tests for Viral and Bacterial Infection, Insulin with One Drop of Blood

A new device about the size of a business card could allow health care providers to test for insulin and other blood proteins, cholesterol, and even signs of viral or bacterial infection all at the same time—with one drop of blood. Preliminary tests of the V-chip, created by scientists at The Methodist Hospital Research Institute and MD Anderson Cancer Center, were published last night by Nature Communications.

20 Dec 2012

Carbon-Nanotube-Coated Ultrasound Acts as Invisible Knife for Noninvasive Surgery

A carbon-nanotube-coated lens that converts light to sound can focus high-pressure sound waves to finer points than ever before. The University of Michigan engineering researchers who developed the new therapeutic ultrasound approach say it could lead to an invisible knife for noninvasive surgery.

20 Dec 2012

Aphios Awarded US Patent Covering Nanoencapsulation of Therapeutic Proteins

Aphios Corporation today announced that it received notification of allowance for a United States Patent entitled “Polymer Microspheres/Nanospheres and Encapsulating Therapeutic Proteins Therein” for the oral delivery of insulin.

From Aphios Corporation 18 Dec 2012

New Study Demonstrates Rapid TB Detection Capability of NanoLogix's BioNanoPore Technology

An independent third-party study by one of the foremost Biomedical Research centers in the U.S. has demonstrated that NanoLogix's BioNanoPore (BNP) Ultra-Fast Identification Technology enables detection of live Tuberculosis cultures in five days as opposed to two+ weeks with traditional methods.

From NanoLogix 17 Dec 2012